Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model

Journal of Immunology

Volumn 182, Issue 6, 2009, Pages 3414-3422

  Omokaro, Stephanie O ^a   Esierto, Marie J D ^a   Eckhaus, Michael A ^b   Ellison, Felicia M ^a   Chen, Jichun ^a   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BONE MARROW DEPRESSION; BONE MARROW HYPOPLASIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL EXPANSION; CELL SELECTION; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; IN VITRO STUDY; INCUBATION TIME; IRRADIATION; LYMPH NODE CELL; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PANCYTOPENIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; BONE MARROW DISEASE; C57BL MOUSE; CELL CLONE; COMPARATIVE STUDY; CONGENIC STRAIN; DISEASE MODEL; GENETICS; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; METABOLISM; MOUSE MUTANT; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BONE MARROW DISEASES; CLONE CELLS; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; LYMPHOCYTE SUBSETS; LYMPHOPROLIFERATIVE DISORDERS; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, MUTANT STRAINS;

EID: 65449165239     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0801430     Document Type: Article

References (54)

1. Young, N. S. 2006. Pathophysiologic mechanisms in acquired aplastic anemia. Hematology Am. Soc. Hematol. Educ. Program 72-77.
2. Maciejewski, J. P., J. R. Hibbs, S. Anderson, P. Katevas, and N. S. Young. 1994. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Exp. Hematol. 22: 1102-1110.
3. Nistico, A., and N. S. Young. 1994. Gamma-Interferon gene expression in the bone marrow of patients with aplastic anemia. Ann. Intern. Med. 120: 463-469.
4. Bacigalupo, A. 2007. Aplastic anemia: pathogenesis and treatment. Hematology Am. Soc. Hematol. Educ. Program 2007: 23-28.
5. Young, N. S., R. T. Calado, and P. Scheinberg. 2006. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108: 2509-2519.
6. Selleri, C., J. P. Maciejewski, T. Sato, and N. S. Young. 1996. Interferon-γ constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood 87: 4149-4157.
7. Barnes, D. W. H., and R. H. Mole. 1967. Aplastic anaemia in sublethally irradiated mice given allogeneic lymph node cells. Br. J. Haematol. 13: 482-491.
8. Chen, J., K. Lipovsky, F. Ellison, R. T. Calado, and N. S. Young. 2004. Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure. Blood 104: 1671-1678.
9. Chen, J., F. M. Ellison, M. A. Eckhaus, A. L. Smith, K. Keyvanfar, R. T. Calado, and N. S. Young. 2007. Minor antigen H60-mediated aplastic anemia is amelio-rated by immunosuppression and the infusion of regulatory T cells. J. Immunol. 178: 4159-4168.
10. Knopse, W. H., S. G. Husseini, K. M. Chiu, and W. Fried. 1994. Immunologically mediated aplastic anemia in mice: evidence of hematopoietic stromal injury and injury to hematopoietic stem cells. Exp. Hematol. 22: 573-581.
11. Bloom, M. L., A. G. Wolk, K. L. Simon-Stoos, J. S. Bard, J. Chen, and N. S. Young. 2004. A mouse model of lymphocyte infusion-induced bone marrow failure. Exp. Hematol. 22: 1163-1172.
12. Callera, F., A. B. Garcia, and R. P. Falcão. 1998. Fas-mediated apoptosis with normal expression of bcl-2 and p53 in lymphocytes from aplastic anaemia. Br. J. Haematol. 100: 698-703.
13. Ismail, M., F. M. Gibson, E. C. Gordon-Smith, and T. R. Rutherford. 2001. Bcl-2 and Bcl-x expression in the CD34+ cells of aplastic anaemia patients: relationship with increased apoptosis and upregulation of Fas antigen. Br. J. Haematol. 113: 706-712.
14. Maciejewski, J. P., C. Selleri, T. Sato, S. Anderson, and N. S. Young. 1995. Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br. J. Haematol. 91: 245-252.
15. Nagata, S., and P. Goldstein. 1995. The Fas death factor. Science 267: 1449-1456.
16. Davidson, W. F., F. J. Dumont, G. B. Hendrick, B. J. Fowlkes, and H. C. Morse III. 1986. Phenotypic, functional and molecular comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice. J. Immunol. 136: 4075-4084.
17. French, L. E., M. Hahne, I. Viard, G. Radlgruber, R. Zanone, K. Becker, C. Muller, and J. Tschopp. 1996. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol. 133: 335-343.
18. Nose, M., M. Nishihara, J. Kamogawa, M. Terada, and S. Nakatsuru. 2000. Genetic basis of autoimmune disease in MRL/lpr mice: dissection of the complex pathological manifestations and their susceptibility loci. Rev. Immunogenet. 2: 154-164.
19. Craft, J., S. Peng, T. Fuji, M. Okada, and S. Fatenejad. 1999. Autoreactive T cells in murine lupus. Immunol. Res. 19: 245-257.
20. Theofilopoulos, A. N. 1995. The basis of autoimmunity: Part II. Genetic predisposition. Immunol. Today 16: 150-159.
21. Hamad, A. R., A. S. Mohamood, C. J. Trujillo, C. T. Huang, E. Yuan, and J. P. Schneck. 2003. B220+ double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production. J. Immunol. 171: 2421-2426.
22. Davidson, W. F., C. Calkins, A. Hugins, T. Giese, and K. L. Holmes. 1991. Cytokine secretion by C3H-lpr and -gld T cells: hypersecretion of IFN-γ and tumor necrosis factor-α by stimulated CD4+ T cells. J. Immunol. 146: 4138-4148.
23. Bettinardi, A., D. Brugoni, E. Quiros-Roldan, A. Malagoli, S. La Grutta, A. Correra, and L. D. Notarangelo. 1997. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood 89: 902-909.
24. Klinman, D. M., and A. D. Steinberg. 1995. Inquiry into murine and human lupus. Immunol. Rev. 144: 157-193.
25. Schneider, E., G. Moreau, A. Arnould, F. Vasseur, N. Khodabaccus, M. Dy, and S. Ezine. 1999. Increased fetal and extramedullary hematopoiesis in Fas-deficient C57BL/6-lpr/lpr mice. Blood 94: 2613-2621.
26. Li, W., J. Fu, F. Wang, G. Yu, Y. Wang, and X. Zhang. 2004. Distinct overexpression of Fas ligand on T lymphocytes in aplastic anemia. Cell. Mol. Immunol. 1: 142-147.
27. Luther-Wyrsch, A., C. Nissen, and A. Wodnar-Filipowicz. 2001. Intracellular Fas ligand is elevated in T lymphocytes in severe aplastic anaemia. Br. J. Haematol. 114: 884-890.
28. Killick, S., C. V. Cox, J. Marsh, E. C. Gordon-Smith, and F. M. Gibson. 2000. Mechanisms of bone marrow progenitor cell apoptosis in aplastic anemia and the effect of anti-thymocyte globulin: examination of the role of the Fas-Fas-L interaction. Br. J. Haematol. 111: 1164-1169.
29. Maciejewski, J., C. Selleri, S. Anderson, and N. S. Young. 1995. Fas antigen expression on CD34+ human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85: 3183-3190.
30. Kakagianni, T., N. C. Giannakoulas, E. Thanopoulou, A. Galani, S. Michalopoulou, A. Kouraklis-Symeonidis, and N. C. Zoumbos. 2006. A probable role for trail-induced apoptosis in the pathogenesis of marrow failure: implications from an in vitro model and from marrow of aplastic anemia patients. Leuk. Res. 30: 713-721.
31. Sloand, E., S. Kim, J. P. Maciejewski, J. Tisdale, D. Follmann, and N. S. Young. 2002. Intracellular interferon-γ in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood 100: 1185-1191.
32. Horikawa, K., H. Nakakuma, T. Kawaguchi, N. Iwamoto, S. Nagakura, T. Kagimoto, and K. Takatsuki. 1997. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelo-dysplastic syndrome. Blood 90: 2761-2722.
33. Kim, S. C., Y. H. Min, S. Lee, S. Y. Chung, N. C. Yoo, J. W. Lee, J. S. Hahn, and Y. W. Ko. 1998. Delayed activation-induced T lymphocytes death in aplastic anemia: related with abnormal Fas system. Korean J. Intern. Med. 13: 41-46.
34. Shinohara, K., T. Takahahi, R. Nawata, and E. Oeda. 1999. Decreased expression of the Fas ligand on peripheral blood mononuclear cells and undetectable levels of soluble Fas ligand in the serum of patients with aplastic anemia and myelo-dysplastic syndrome. Am. J. Hematol. 62: 124-125.
35. Atkinson, M. A., and E. H. Leiter. 1999. The NOD mouse model of type 1 diabetes: as good as it gets? Nat. Med. 5: 601-604.
36. Boyton, R. J., and D. M. Altmann. 2002. Transgenic models of autoimmune disease. Clin. Exp. Immunol. 127: 4-11.
37. Cunninghame Graham, D. S., and T. J. Vyse. 2004. The candidate gene approach: have murine models informed the study of human SLE? Clin. Exp. Immunol. 137: 1-7.
38. Every, A. L., D. R. Kramer, S. I. Mannering, A. M. Lew, and L. C. Harrison. 2006. Intranasal vaccination with proinsulin DNA induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes. J. Immunol. 176: 4608-4615.
39. Jones, R. E., D. Bourdette, N. Moes, A. Vandenbark, A. Zamora, and H. Offner. 2003. Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis. J. Immunol. 170: 1690-1698.
40. McMahon, E. J., S. L. Bailey, C. V. Castenada, H. Waldner, and S. D. Miller. 2005. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11: 339.
41. Ono, M., J. Shimizu, Y. Miyachi, and S. Sakaguchi. 2006. Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein (high), Foxp3-expressing CD25+ and CD25- regulatory T cells. J. Immunol. 176: 4748-4756.
42. Weber, S. E., J. Harbertson, E. Godebu, G. A. Mros, R. C. Padrick, B. D. Carson, S. F. Ziegler, and L. M. Bradley. 2006. Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J. Immunol. 176: 4730-4739.
43. Yu, M., J. J. Johnson, and V. K. Tuohy. 1996. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis forpeptide-specific therapy after onset of clinical disease. J. Exp. Med. 183: 1777-1788.
44. Salbeko-Downes, K. A., J. H. Russell, and A. H. Cross. 1999. Role of Fas-FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease. J. Neuroimmunol. 100: 42-52.
45. Mombaerts, P., E. Mizoguchi, M. J. Grusby, L. H. Glimcher, A. K. Bhan, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75: 203-205.
46. Krammer, P. H. 2000. CD95's deadly mission in the immune system. Nature 407: 789-795.
47. Solomou, E. E., F. Gibellini, B. Stewart, D. Malide, M. Berg, V. Visconte, S. Green, R. Childs, S. J. Chanock, and N. S. Young. 2007. Perforin gene mutations in patients with acquired aplastic anemia. Blood 109: 5234-5237.
48. Merger, M., J. L. Viney, R. Borojevic, D. Steele-Norwood, D. A. Clark, R. Riddell, R. Maric, E. R. Podack, and K. Croitoru. 2002. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor α in T cell induced mucosal damage in the mouse intestine. Gut 51: 155-163.
49. Zeng, W., S. Kajigaya, G. Chen, A. M. Risitano, O. Nunez, and N. S. Young. 2004. Transcript profile of CD4+ and CD8+ T cells from the bone marrow of acquired aplastic anemia patients. Exp. Hemat. 32: 806-814.
50. Maratheftis, C. I., E. Andreakos, H. M. Moutsopoulos, and M. Voulgarelis. 2005. Toll-like receptor is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes. Clin. Cancer Res. 13: 1154-1160.
51. Maciejewski, J., C. Selleri, T. Sato, S. Anderson, and N. S. Young. 1996. A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. Blood 88: 1983-1991.
52. Baruque, G. A., M. A. Bitencourt, R. Pasquini, M. T. Castelo-Branco, J. C. Llerena, Jr., and V. M. Rumjanek. 2005. Apoptosis and expression of antiand pro-apoptotic proteins in peripheral blood mononuclear cells of Fanconi anaemia patients: a study of 73 cases. Eur. J. Haematol. 75: 384-390.
53. Sloand, E. M., S. Kim, M. Fuhrer, A. M. Risitano, R. Nakamura, J. P. Maciejewski, A. J. Barrett, and N. S. Young. 2002. Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities. Blood 100: 4427-4432.
54. Selleri, C., T. Sato, L. Del Vecchio, L. Luciano, A. J. Barrett, B. Rotoli, N. S. Young, and J. P. Maciejewski. 1997. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-α in chronic myelogenous leukemia. Blood 89: 957-964.